HC Wainwright & Co. Maintains Buy on MediWound, Raises Price Target to $26
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Swayampakula Ramakanth maintains a 'Buy' rating on MediWound (NASDAQ:MDWD) and raises the price target from $23 to $26.
September 21, 2023 | 12:24 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
HC Wainwright & Co. maintains a 'Buy' rating on MediWound and raises the price target from $23 to $26.
The 'Buy' rating maintained by HC Wainwright & Co. and the increase in price target from $23 to $26 indicates a positive outlook for MediWound. This could potentially attract more investors, driving the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100